X
Xiaoyang Liang
Researcher at Tianjin University
Publications - 15
Citations - 72
Xiaoyang Liang is an academic researcher from Tianjin University. The author has contributed to research in topics: Chemistry & Medicine. The author has co-authored 4 publications.
Papers
More filters
Journal ArticleDOI
Mutual-reinforcing sonodynamic therapy against Rheumatoid Arthritis based on sparfloxacin sonosensitizer doped concave-cubic rhodium nanozyme.
TL;DR: Wang et al. as mentioned in this paper developed a sonosensitizer spafloxacin (SPX) doped and human serum albumin (HSA) loaded concave-cubic rhodium (Rh) nanozyme to realize mutual-reinforcing sonodynamic therapy during ultrasonic activation.
Journal ArticleDOI
Palladium Hydride Nanopocket Cubes and Their H2-Therapy Function in Amplifying Inhibition of Foam Cells to Attenuate Atherosclerosis
TL;DR: The palladium hydride nanopocket cubes significantly reduce lipid storage and plaque formation in Western diet‐fed apolipoprotein E‐deficient mice without obvious long‐term toxicity and shows promising to be further developed as a high efficacy and low toxicity method to treat atherosclerosis.
Journal ArticleDOI
Platinum-cerium bimetallic nano-raspberry for atherosclerosis treatment via synergistic foam cell inhibition and P2Y12 targeted antiplatelet aggregation
TL;DR: In this paper, a raspberry-liked platinum and cerium bimetallic nanostructures (PtCe NRs) with ticagrelor loading and PEGylation were designed to weaken the plaques for atherosclerosis treatment via synergistic foam cell inhibition and antiplatelet aggregation.
Journal ArticleDOI
Enhanced macrophage polarization induced by COX-2 inhibitor-loaded Pd octahedral nanozymes for treatment of atherosclerosis
TL;DR: In this article , a combination of ALO and hyaluronic acid (HA)-modified palladium (Pd) octahedral nanozymes was proposed to induce macrophage polarization to reduce plaque formation.
Journal ArticleDOI
Sequential delivery for hepatic fibrosis treatment based on carvedilol loaded star-like nanozyme.
TL;DR: In this paper, a sequential delivery strategy based on autophagy inhibitor carvedilol (CAR) loaded and hyaluronic acid modified star-like Au nanozyme (Au NS@CAR-HA) for targeted HSCs suppression was proposed.